Heart failure has a high prevalence in older populations, is a common and growing cause for hospital admission and carries a high risk of morbidity and mortality. Important co-morbidities in older patients with heart failure include atrial fibrillation, renal impairment, hypertension and anaemia. Diagnosing and managing heart failure in older patients are complicated due to atypical presentations, co-morbidities and a relative lack of evidence for commonly used treatments in younger patients. The growing epidemic of heart failure is also under-recognised and resourced in most health systems. Despite potential differences, we recommend that the basic approach to manage heart failure patients with an ejection fraction (EF) o
The aging population, higher burden of predisposing conditions and comorbidities along with improvem...
International audienceMultidisciplinary management of worsening heart failure (HF) in the elderly im...
Abstract Aims The heart failure (HF) prognosis in older patients remains poor with a high 5‐years mo...
Heart failure has a high prevalence in older populations, is a common and growing cause for hospital...
The aging population, higher burden of predisposing conditions and comorbidities along with improvem...
Advanced age is a relevant risk factor for the heart failure (HF). The development of new pharmacolo...
This author manuscript is made available in accordance with the publisher's Self-Archiving policy T...
Heart failure (HF) is a common condition affecting predominantly older people. Symptoms include brea...
Over the past 30 years, the prevalence and incidence of heart failure (HF) have increased markedly w...
SummaryOver the past 30 years, the prevalence and incidence of heart failure (HF) have increased mar...
The prevalence of heart failure (HF) increases with age. While clinical trials suggest that contempo...
Heart failure is a progressive and often fatal disorder. The prevalence and incidence of heart failu...
Heart failure (HF) is a clinical syndrome that is increasingly affecting elderly patients. Before 20...
Heart failure is common. It affects, depending on defini-tion, between 1–5 % of the population or be...
The aging population, higher burden of predisposing conditions and comorbidities along with improvem...
The aging population, higher burden of predisposing conditions and comorbidities along with improvem...
International audienceMultidisciplinary management of worsening heart failure (HF) in the elderly im...
Abstract Aims The heart failure (HF) prognosis in older patients remains poor with a high 5‐years mo...
Heart failure has a high prevalence in older populations, is a common and growing cause for hospital...
The aging population, higher burden of predisposing conditions and comorbidities along with improvem...
Advanced age is a relevant risk factor for the heart failure (HF). The development of new pharmacolo...
This author manuscript is made available in accordance with the publisher's Self-Archiving policy T...
Heart failure (HF) is a common condition affecting predominantly older people. Symptoms include brea...
Over the past 30 years, the prevalence and incidence of heart failure (HF) have increased markedly w...
SummaryOver the past 30 years, the prevalence and incidence of heart failure (HF) have increased mar...
The prevalence of heart failure (HF) increases with age. While clinical trials suggest that contempo...
Heart failure is a progressive and often fatal disorder. The prevalence and incidence of heart failu...
Heart failure (HF) is a clinical syndrome that is increasingly affecting elderly patients. Before 20...
Heart failure is common. It affects, depending on defini-tion, between 1–5 % of the population or be...
The aging population, higher burden of predisposing conditions and comorbidities along with improvem...
The aging population, higher burden of predisposing conditions and comorbidities along with improvem...
International audienceMultidisciplinary management of worsening heart failure (HF) in the elderly im...
Abstract Aims The heart failure (HF) prognosis in older patients remains poor with a high 5‐years mo...